Chronic hepatitis C in Italy: The vanishing of the first and most consistent epidemic wave

Digestive and Liver Disease

Volumn 45, Issue 5, 2013, Pages 369-370

  Puoti, Massimo ^a   Girardi, Enrico ^b  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ANTIVIRAL THERAPY; BLOODBORNE BACTERIUM; DEVELOPED COUNTRY; GROUPS BY AGE; HEPATITIS C; HIGH RISK POPULATION; HUMAN; ITALY; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; NOTE; PRIMARY PREVENTION; PRIORITY JOURNAL; SEROCONVERSION;

FEMALE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; MALE; RNA, VIRAL;

EID: 84876702317     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2013.02.012     Document Type: Note

References (8)

1. Mohd Hanafiah K., Groeger J., Flaxman A.D., Wiersma S.T. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2012, [Epub ahead of print]. 10.1002/hep.26141.
2. Cornberg M., Razavi H.A., Alberti A., et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver International 2011, 31(Suppl. 2):30-60.
3. Mariano A., Scalia Tomba G., Tosti M.E., Spada E., Mele A. Estimating the incidence, prevalence and clinical burden of hepatitis C over time in Italy. Scandinavian Journal of Infectious Diseases 2009, 41:689-699.
4. Stroffolini T., Guadagnino V., Chionne P., et al. A population based survey of hepatitis B virus infection in a southern Italian town. Italian Journal of Gastroenterology and Hepatology 1997, 29:415-418.
5. Guadagnino V., Stroffolini T., Caroleo B., et al. Hepatitis C virus infection in an endemic area of Southern Italy 14 years later: evidence for a vanishing infection. Digestive and Liver Disease 2013, 45:403-407.
6. El-Kamary S.S., Jhaveri R., Shardell M.D. All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population. Clinical Infectious Diseases 2011, 53:150-157.
7. Bertuccio P., Bosetti C., Levi F., et al. A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe. Annals of Oncology 2013, [Epub ahead of print].
8. Soriano V., Labarga P., Fernández-Montero J.V., et al. The changing face of hepatitis C in the new eraof direct-acting antivirals. Antiviral Research 2013, 97:36-40.